国际标准期刊号: 2165-7904

肥胖与减肥治疗杂志

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • 哥白尼索引
  • 谷歌学术
  • 打开 J 门
  • Genamics 期刊搜索
  • 国际农业与生物科学中心 (CABI)
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • SWB 在线目录
  • CABI 全文
  • 出租车直达
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
  • 布里斯托大学
  • 出版医学
  • ICMJE
分享此页面

抽象的

Skin Problems in the Lower Legs of Morbidly Obese Patients and the Possible Role of Bariatric Surgery

William R Parkyn, Cheng Yee Chan and Andre M Van Rij

Objective: Anecdotally, lower leg skin changes in morbidly obese people appear much improved with weight loss following bariatric surgery. The objective of this study was to compare prevalence of lower leg symptoms in obese patients awaiting, and those who have had, bariatric surgery. Methods: An audit was undertaken, utilising questionnaires, to identify obesity-associated lower leg symptoms: swelling, itchiness, colour changes, hot/burning feeling, eczema and ulcers. There were three groups: those awaiting surgery (‘Obesity Clinic’), those who had surgery (‘Post-Surgery’), and those in ‘Post-Surgery’ recalling pre-operative symptoms (‘Pre-Surgery Recall’). Results: Participants totalled 117; 62 in ‘Obesity Clinic’ and 55 in ‘Post-Surgery’ (81.8% response rate). Overall prevalence of symptoms was significantly lower in ‘Post-Surgery’ (36.4%) compared to ‘Obesity Clinic’ (80.6%) and ‘Pre-Surgery Recall’ (74.5%) (p<0.0001). Individual symptoms were also similarly less prevalent. Conclusion: These results establish the high prevalence of lower leg skin changes in morbidly obese patients, which is significantly lower in those who have undergone bariatric surgery, possibly due to improved underlying venous stasis from decreased intra-abdominal pressure and weight. Decreased popliteal vein compression from weight loss, and weight reduction itself may also be contributing factors. This suggests a role for bariatric surgery in the potentially cost-effective treatment of lower leg symptoms in the morbidly obese.